Scancell Holdings Plc Stock Analysis
| SCNLF Stock | USD 0.19 0.00 0.00% |
Scancell Holdings plc holds a debt-to-equity ratio of 0.351. Scancell Holdings' financial risk is the risk to Scancell Holdings stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Scancell Holdings' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Scancell Holdings' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Scancell Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Scancell Holdings' stakeholders.
For many companies, including Scancell Holdings, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Scancell Holdings plc, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Scancell Holdings' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Scancell Holdings' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Scancell Holdings is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Scancell Holdings to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Scancell Holdings is said to be less leveraged. If creditors hold a majority of Scancell Holdings' assets, the Company is said to be highly leveraged.
Scancell Holdings plc is overvalued with Real Value of 0.15 and Hype Value of 0.19. The main objective of Scancell Holdings pink sheet analysis is to determine its intrinsic value, which is an estimate of what Scancell Holdings plc is worth, separate from its market price. There are two main types of Scancell Holdings' stock analysis: fundamental analysis and technical analysis.
The Scancell Holdings pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Scancell Holdings' ongoing operational relationships across important fundamental and technical indicators.
Scancell |
Scancell Pink Sheet Analysis Notes
About 49.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.01. Scancell Holdings plc had not issued any dividends in recent years. Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom. Scancell Holdings operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 25 people.The quote for Scancell Holdings plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Scancell Holdings plc contact Pr Durrant at 44 18 6558 2066 or learn more at https://www.scancell.co.uk.Scancell Holdings plc Investment Alerts
| Scancell Holdings has some characteristics of a very speculative penny stock | |
| Scancell Holdings appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (2.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Scancell Holdings plc has accumulated about 35.57 M in cash with (10.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. |
Scancell Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 435.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Scancell Holdings's market, we take the total number of its shares issued and multiply it by Scancell Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Scancell Profitablity
The company has Profit Margin (PM) of (1.6) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.06.Technical Drivers
As of the 17th of February 2026, Scancell Holdings has the Risk Adjusted Performance of 0.1075, coefficient of variation of 812.4, and Variance of 19.33. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scancell Holdings plc, as well as the relationship between them. Please validate Scancell Holdings plc mean deviation, total risk alpha, as well as the relationship between the Total Risk Alpha and kurtosis to decide if Scancell Holdings is priced more or less accurately, providing market reflects its prevalent price of 0.19 per share. As Scancell Holdings plc appears to be a penny stock we also recommend to double-check its information ratio numbers.Scancell Holdings plc Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Scancell Holdings middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Scancell Holdings plc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Scancell Holdings Predictive Daily Indicators
Scancell Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Scancell Holdings pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Scancell Holdings Forecast Models
Scancell Holdings' time-series forecasting models are one of many Scancell Holdings' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Scancell Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Scancell Holdings plc Debt to Cash Allocation
Many companies such as Scancell Holdings, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Scancell Holdings plc has accumulated 7.01 M in total debt with debt to equity ratio (D/E) of 0.35, which is about average as compared to similar companies. Scancell Holdings plc has a current ratio of 23.57, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Scancell Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Scancell Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Scancell Holdings plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Scancell to invest in growth at high rates of return. When we think about Scancell Holdings' use of debt, we should always consider it together with cash and equity.Scancell Holdings Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Scancell Holdings' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Scancell Holdings, which in turn will lower the firm's financial flexibility.About Scancell Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Scancell Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Scancell shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Scancell Holdings. By using and applying Scancell Pink Sheet analysis, traders can create a robust methodology for identifying Scancell entry and exit points for their positions.
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom. Scancell Holdings operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 25 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Scancell Holdings to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Complementary Tools for Scancell Pink Sheet analysis
When running Scancell Holdings' price analysis, check to measure Scancell Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scancell Holdings is operating at the current time. Most of Scancell Holdings' value examination focuses on studying past and present price action to predict the probability of Scancell Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scancell Holdings' price. Additionally, you may evaluate how the addition of Scancell Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world |